Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer

door Mascaux, C
Gepubliceerd in 2006

Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer

door Zielinski, C., Knapp, S., Mascaux, C., Hirsch, F.
Gepubliceerd in 2013

Is an alcoholic fixative fluid used for manual liquid-based cytology accurate to perform HPV tests?

door Garbar C, Mascaux C, De Graeve P, Delvenne P
Gepubliceerd in 2011-12-01

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

door Martin, B, Paesmans, M, Mascaux, C, Berghmans, T, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Gepubliceerd in 2004

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

door Meert, A-P, Paesmans, M, Martin, B, Delmotte, P, Berghmans, T, Verdebout, J-M, Lafitte, J-J, Mascaux, C, Sculier, J-P
Gepubliceerd in 2002

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

door Meert, A-P, Martin, B, Paesmans, M, Berghmans, T, Mascaux, C, Verdebout, J-M, Delmotte, P, Lafitte, J-J, Sculier, J-P
Gepubliceerd in 2003

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

door Mascaux, C, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Gepubliceerd in 2006

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

door Mascaux, C, Iannino, N, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Noel, S, Lafitte, J-J, Sculier, J-P
Gepubliceerd in 2005

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

door Sculier, J P, Ghisdal, L, Berghmans, T, Branle, F, Lafitte, J J, Vallot, F, Meert, A P, Lemaitre, F, Steels, E, Burniat, A, Mascaux, C, Paesmans, M
Gepubliceerd in 2001

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

door Martin, B, Paesmans, M, Berghmans, T, Branle, F, Ghisdal, L, Mascaux, C, Meert, A-P, Steels, E, Vallot, F, Verdebout, J-M, Lafitte, J-J, Sculier, J-P
Gepubliceerd in 2003

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

door Mazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A.B., Mezquita, L., Thai, A.A., Mascaux, C., Couraud, S., Veillon, R., Van den Heuvel, M., Neal, J., Peled, N., Früh, M., Ng, T.L., Gounant, V., Popat, S., Diebold, J., Sabari, J., Zhu, V.W., Rothschild, S.I., Bironzo, P., Martinez-Marti, A., Curioni-Fontecedro, A., Rosell, R., Lattuca-Truc, M., Wiesweg, M., Besse, B., Solomon, B., Barlesi, F., Schouten, R.D., Wakelee, H., Camidge, D.R., Zalcman, G., Novello, S., Ou, S.I., Milia, J., Gautschi, O.
Gepubliceerd in Ann Oncol (2019)